Although the BA-mediated transcriptional activities of NF-κB vary in cancers [10, 23], the dysregulation of the NF-κB pathway is closely related to ROS levels and cellular redox balance [24–26]; however, this phenomenon has not yet been tested in MM, and its potential mechanism remains a mystery. Here, NFKB1 is linked to cancer.